Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amy Guo

Showing results (21-30 of 65) with videos related to

Pageof 7
Sort By:
Clinical Breast Cancer|June 14, 2011
Treatment persistence with monthly zoledronic acid is associated with lower risk and frequency of skeletal complications in patients with breast cancer and bone metastasisHind T Hatoum, Swu-Jane Lin, Matthew R Smith, et al.
Transfusion|April 11, 2012
Economic impact on US Medicare of a new diagnosis of myelodysplastic syndromes and the incremental costs associated with blood transfusion needStuart L Goldberg, Er Chen, Medha Sasane, et al.
Advances in Therapy|October 30, 2023
Health Economic Assessments of Hyaluronic Acid Treatments for Knee Osteoarthritis: A Systematic ReviewAnil Ranawat, Kaiwen Guo, Mark Phillips, et al.
International Journal of Hygiene and Environmental Health|December 28, 2020
Environmental conditions in maternity wards: Evidence from rural healthcare facilities in 14 low- and middle-income countriesRyan Cronk, Amy Guo, Caroline Folz, et al.
Electrophoresis|May 22, 2008
Electrophoretic evidence for the presence of structural isoforms specific for the IgG2 isotypeAmy Guo, Mei Han, Theresa Martinez, et al.
Journal of Managed Care & Specialty Pharmacy|June 27, 2017
Inpatient Admissions and Costs Associated with Persistent Use of Dalfampridine Extended-Release in Multiple Sclerosis: A Claims Database AnalysisAmy Guo, Alexander Niyazov, Dendy Macaulay, et al.
Clinicoeconomics and Outcomes Research : CEOR|June 9, 2016
Treatment patterns and health care resource utilization associated with dalfampridine extended release in multiple sclerosis: a retrospective claims database analysisAmy Guo, Michael Grabner, Swetha Rao Palli, et al.
Advances in Therapy|February 5, 2021
The Impact of Progression on Healthcare Resource Utilization and Costs Among Patients with High-Grade Non-Muscle Invasive Bladder Cancer After Bacillus Calmette-Guérin Therapy: A Retrospective SEER-Medicare AnalysisMin Yang, Mihaela V Georgieva, Iryna Bocharova, et al.
North American Spine Society Journal|July 29, 2025
Real-world treatment patterns and management gaps of lumbar disc herniation in the United StatesAmit Bhandutia, Min Yang, Qing Liu, et al.
Current Medical Research and Opinion|November 11, 2010
Retrospective real-world comparison of medical visits, costs, and adherence between nilotinib and dasatinib in chronic myeloid leukemiaEric Q Wu, Annie Guerin, Andrew P Yu, et al.
Pageof 7

Showing results (21-30 of 65) with videos related to

Sort By:
Pageof 7
Clinical Breast Cancer|June 14, 2011
Treatment persistence with monthly zoledronic acid is associated with lower risk and frequency of skeletal complications in patients with breast cancer and bone metastasisHind T Hatoum, Swu-Jane Lin, Matthew R Smith, et al.
Transfusion|April 11, 2012
Economic impact on US Medicare of a new diagnosis of myelodysplastic syndromes and the incremental costs associated with blood transfusion needStuart L Goldberg, Er Chen, Medha Sasane, et al.
Advances in Therapy|October 30, 2023
Health Economic Assessments of Hyaluronic Acid Treatments for Knee Osteoarthritis: A Systematic ReviewAnil Ranawat, Kaiwen Guo, Mark Phillips, et al.
International Journal of Hygiene and Environmental Health|December 28, 2020
Environmental conditions in maternity wards: Evidence from rural healthcare facilities in 14 low- and middle-income countriesRyan Cronk, Amy Guo, Caroline Folz, et al.
Electrophoresis|May 22, 2008
Electrophoretic evidence for the presence of structural isoforms specific for the IgG2 isotypeAmy Guo, Mei Han, Theresa Martinez, et al.
Journal of Managed Care & Specialty Pharmacy|June 27, 2017
Inpatient Admissions and Costs Associated with Persistent Use of Dalfampridine Extended-Release in Multiple Sclerosis: A Claims Database AnalysisAmy Guo, Alexander Niyazov, Dendy Macaulay, et al.
Clinicoeconomics and Outcomes Research : CEOR|June 9, 2016
Treatment patterns and health care resource utilization associated with dalfampridine extended release in multiple sclerosis: a retrospective claims database analysisAmy Guo, Michael Grabner, Swetha Rao Palli, et al.
Advances in Therapy|February 5, 2021
The Impact of Progression on Healthcare Resource Utilization and Costs Among Patients with High-Grade Non-Muscle Invasive Bladder Cancer After Bacillus Calmette-Guérin Therapy: A Retrospective SEER-Medicare AnalysisMin Yang, Mihaela V Georgieva, Iryna Bocharova, et al.
North American Spine Society Journal|July 29, 2025
Real-world treatment patterns and management gaps of lumbar disc herniation in the United StatesAmit Bhandutia, Min Yang, Qing Liu, et al.
Current Medical Research and Opinion|November 11, 2010
Retrospective real-world comparison of medical visits, costs, and adherence between nilotinib and dasatinib in chronic myeloid leukemiaEric Q Wu, Annie Guerin, Andrew P Yu, et al.
Pageof 7